Drugs of Abuse Testing

In this presentation:

Our speaker for this program, Dr. Loralie Langman, will discuss the prevalence of illicit drug use in the United States and describe testing for commonly encountered drugs. She will also review drug detection limits, confirmation cutoffs, drug metabolism, and interpretation of screening and confirmation drug testing.

Dr. Loralie J. Langman is a consultant in the Division of Clinical Biochemistry and Immunology and Associate Professor of Laboratory Medicine and Pathology in the College of Medicine. Dr. Langman is also the Director of the Toxicology and Drug Monitoring Laboratory at Mayo Clinic in Rochester, Minnesota.

Closed Captioning is available for this program. Click the CC box in the lower right to turn on the captions.

View the presentation

Viewing Tips

• Before viewing, print the user-friendly Notes Pages.
• After viewing, obtain a Record of Viewing.

Related Tests

• #80917 Drug Abuse Survey with Confirmation, Evaluation 1, Urine
• #80918 Drug Abuse Survey with Confirmation, Evaluation 2, Urine
• #80919 Drug Abuse Survey with Confirmation, Evaluation 3, Urine
• #80373 Drug Abuse Survey with Confirmation, Panel 5, Urine
• #81410 Drug Abuse Survey with Confirmation, Evaluation 12, Urine
• #9446 Drug Abuse Survey with Confirmation, Urine
• #8248 Drug Abuse Survey, Urine

Related Information

• Learn more about Loralie J. Langman, PhD DABCC (CC, MD, TC), DABFT
• Learn more about the Division of Clinical Biochemistry and Immunology.

Send to a Colleague

We invite you to forward this presentation to a colleague.